| Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer | |
| Li, Fei; Zhang, Shu-Hua; Pang, Li-Min | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:49 |
| 关键词 | advanced/metastatic non-small-cell lung cancer targeted therapy efficacy adverse events randomized controlled trials |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3514359 |
| 专题 | 吉林大学白求恩第三医院 |
| 推荐引用方式 GB/T 7714 | Li, Fei,Zhang, Shu-Hua,Pang, Li-Min. Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer[J]. ONCOTARGET,2017,8(49). |
| APA | Li, Fei,Zhang, Shu-Hua,&Pang, Li-Min.(2017).Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.ONCOTARGET,8(49). |
| MLA | Li, Fei,et al."Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer".ONCOTARGET 8.49(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论